Evotec on the move18 Aug 2020 08:53
EVOTEC CONTRIBUTES ACCESS TO UNIQUE CHRONIC KIDNEY DISEASE ("CKD") PATIENT DATABASES AS WELL AS ITS INTEGRATED MODALITY-AGNOSTIC DRUG DISCOVERY PLATFORM
EVOTEC WILL RECEIVE AN UPFRONT PAYMENT, RESEARCH FUNDING, MILESTONE POTENTIAL ABOVE € 150 M PER PROJECT AND TIERED ROYALTIES.